F500-2020-135-Amgen
Courtesy of Amgen

Company Information

As of 2/1/2023
Country
U.S.
Headquarters
Thousand Oaks, Calif.
Industry
Pharmaceuticals
CEO
Robert A. Bradway
Company Type
Public
Ticker
AMGN
Revenues ($M)
$26,330
Profits ($M)
$6,835
Market Value ($M)
$140,459
Employees
24,200
Figures are for the latest twelve months ended Sept. 30, 2022. Market value as of Jan. 20, 2023. Sources: Bloomberg; S&P Global.

Key Financials (Last Fiscal Year)

$ millions
% change
Revenues ($M)
$25,979
2.2%
Profits ($M)
$5,893
-18.9%
Assets ($M)
$61,165
-
Total Stockholder Equity ($M)
$6,700
-

Profit Ratios

Profit as % of Revenues
22.7%
Profits as % of Assets
9.6%
Profits as % of Stockholder Equity
88%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)
1,028
EPS % Change (from 2020)
-16.5%
EPS % Change (5 year annual rate)
0.1%
EPS % Change (10 year annual rate)
9.8%

Total Return

Total Return to Investors (2021)
1%
Total Return to Investors (5 year, annualized)
12.2%
Total Return to Investors (10 year, annualized)
16.2%

Amgen Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2021$25,4248.8%$7,264-7.4%$62,948$9,409
2020$23,362-1.6%$7,842-6.6%$59,707$9,673
2019$23,7473.9%$8,394324.2%$66,416$12,500
2018$22,849-0.6%$1,979-74.4%$79,954$25,241
2017$22,9916.1%$7,72211.3%$77,626$29,875
SHOW MORE
FortuneDataStore ad
Lists ranking Amgen
RANK140
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MORE
RANK100000
World's Most Admired Companies - 2023The 25th Fortune World’s Most Admired Companies li...READ MORE